SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmacopeia, Inc. (ACCL) (Prev: PCOP)
ACCL 4.050-8.0%Nov 4 3:58 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Lang who wrote ()11/13/1998 2:32:00 PM
From: kinkblot  Read Replies (1) of 179
 
Interesting post from "lih" on the Yahoo PCOP thread:
messages.yahoo.com@m2.yahoo.com

He must be referring to D.E.Shaw & Co., a "global investment bank" known for its quantitative trading strategies.

D.E. Shaw & Co. - deshaw.com

The [Technology Venture Financing] link brings up a page that describes their MSI investment, among others.

Shaw's problems are mentioned in this Wall Street City article 10/22:
wallstreetcity.com

...Bank of America made a $357 million loss write-off due to its partcipation in the troubled hedge fund D.E. Shaw, and bought $20 billion in outstanding securities and derivatives contracts from that hedge fund in order to prevent its demise...

In the merger Joint Proxy Statement / Prospectus, page 97,
D.E. Shaw Investment Group, LP is listed as a beneficial owner of 1,274,578 shares or 6.8% of the outstanding shares post-merger. They held 186,278 MSI common and 2,222,223 MSI preferred shares which were converted to PCOP common shares at the exchange ratio of 0.5292 to 1.

Someone has been selling continuously for about two weeks now ...maybe it's these guys, Shaw or Bank of America.

WT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext